Keywords: NSAID; non-steroidal anti-inflammatory drug; CENTRAL; Cochrane Central Register of Controlled Trials; HRSD; Hamilton Rating Scale for Depression; MDD; Major Depressive Disorder; WHO; World Health Organization; IL-6; interleukin-6; IL-1β; interleukin-1bet